| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/06/2001 | US6197508 Electrochemical denaturation and annealing of nucleic acid |
| 03/06/2001 | US6197505 Nucleic acid derived from human gene which encodes angiotensin converting enzyme and which is polymorphic at one or several positions; screening for predisposition; assessing responsiveness of individual to treatment regimen |
| 03/06/2001 | US6197502 Expression cloning processes for the discovery characterization, and isolation of genes encoding polypeptides with a predetermined property |
| 03/06/2001 | US6197500 For hybridization probes and amplification primers used to diagnose the presence or absence of a fragile x allele in an individual |
| 03/06/2001 | US6197498 DNA diagnostics based on mass spectrometry |
| 03/06/2001 | US6197332 Lipid-conjugated polyamide compounds and related compositions and methods thereof |
| 03/06/2001 | US6197313 Ryegrass pollen allergen |
| 03/06/2001 | US6197312 Surface antigen |
| 03/06/2001 | US6197310 Causative agent of the mystery swine disease, vaccine compositions and diagnostics kits |
| 03/06/2001 | US6197301 Compositions and methods for the prevention and diagnosis of Lyme disease |
| 03/06/2001 | US6197300 ftsZ |
| 03/06/2001 | US6197297 Monoclonal antibody specific to polypeptide which induces interferon-gamma production |
| 03/06/2001 | US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy |
| 03/06/2001 | US6197293 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
| 03/06/2001 | CA1341198C Monoclonal antibodies against melanoma-associated antigens, hybrid cell lines producing these antibodies, and use therefor |
| 03/06/2001 | CA1341197C Gm-csf protein, its derivatives, the preparation of proteins of this type, and their use |
| 03/01/2001 | WO2001014593A2 A method for producing quality assured biological sample and composition containing the same |
| 03/01/2001 | WO2001014591A1 High sensitivity biomolecule detection with magnetic particles |
| 03/01/2001 | WO2001014590A2 Simultaneous isolation and quantitation of dna |
| 03/01/2001 | WO2001014587A1 METHOD OF DETECTING AND QUANTITATING MICROORGANISM HAVING SPECIFIC FUNTION AND ITS GENE FROM NATURAL ENVIRONMENT, NOVEL 16SrRNA GENE DATA AND PROBES |
| 03/01/2001 | WO2001014581A2 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 03/01/2001 | WO2001014580A1 Diagnostic assays of secreted biological fluids for detection of infection and inflammatory conditions |
| 03/01/2001 | WO2001014578A1 Methods for the detection, analysis and isolation of nascent proteins |
| 03/01/2001 | WO2001014574A1 D-gluconolactone oxidase gene and method for producing recombinant d-gluconolactone oxidase |
| 03/01/2001 | WO2001014573A1 Duplicated cassava vein mosaic virus enhancers and uses thereof |
| 03/01/2001 | WO2001014572A2 Plant gene expression, controlled by constitutive plant v-atpase promoters |
| 03/01/2001 | WO2001014571A1 Commercial production of chymosin in plants |
| 03/01/2001 | WO2001014570A1 Activatable recombinant neurotoxins |
| 03/01/2001 | WO2001014569A2 Increasing the polysaccharide content in plants |
| 03/01/2001 | WO2001014568A1 Taq dna polymerases having an amino acid substitution at e681 and homologs thereof exhibiting improved salt tolerance |
| 03/01/2001 | WO2001014567A1 Process for producing coenzyme q¿10? |
| 03/01/2001 | WO2001014566A2 Enzymatic synthesis of deoxyribonucleosides |
| 03/01/2001 | WO2001014565A1 Pigment production by cells having introduced cytochrome p450 sequences |
| 03/01/2001 | WO2001014564A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | WO2001014562A1 Hybrid insecticidal toxins and nucleic acid sequences coding therefor |
| 03/01/2001 | WO2001014561A1 Nor gene compositions and methods for use thereof |
| 03/01/2001 | WO2001014560A1 GENES ENCODING PROTEINS REGULATING pH OF VACUOLES |
| 03/01/2001 | WO2001014559A1 Gene regulating plant branching, vector containing the gene, microorganism transformed by the vector, and method for regulating plant branching by using the microorganism |
| 03/01/2001 | WO2001014558A1 Human antibodies or fragments thereof binding to hla-cw6 |
| 03/01/2001 | WO2001014557A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | WO2001014556A1 Novel b7-4 molecules and uses therefor |
| 03/01/2001 | WO2001014555A1 Human narcolepsy gene |
| 03/01/2001 | WO2001014554A1 G protein-coupled receptor expressed in brain |
| 03/01/2001 | WO2001014553A1 Compositions isolated from bovine mammary gland and methods for their use |
| 03/01/2001 | WO2001014552A1 Meg-1 protein |
| 03/01/2001 | WO2001014551A1 NOVEL bHLH TYPE TRANSCRIPTION FACTOR GENE DEC2 |
| 03/01/2001 | WO2001014550A1 Prostate cancer-relased gene 3 (pg-3) and biallelic markers thereof |
| 03/01/2001 | WO2001014549A1 Gas1 polypeptides |
| 03/01/2001 | WO2001014548A2 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | WO2001014547A1 Novel abc transporter and uses thereof |
| 03/01/2001 | WO2001014546A2 Replication protein a binding transcriptional factor (rbt1) and uses thereof |
| 03/01/2001 | WO2001014545A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 03/01/2001 | WO2001014544A1 Novel response element |
| 03/01/2001 | WO2001014543A1 Novel dna fragment elevating gene expression dose |
| 03/01/2001 | WO2001014542A1 A transmembrane trap for isolating membrane bound proteins |
| 03/01/2001 | WO2001014541A1 A method for preparation of dna from biological material |
| 03/01/2001 | WO2001014540A2 Starch synthase isoform v |
| 03/01/2001 | WO2001014539A2 Methods and compositions for the construction and use of fusion libraries |
| 03/01/2001 | WO2001014538A2 Plants with modified polyunsaturated fatty acids |
| 03/01/2001 | WO2001014537A1 Piggybac transformation system |
| 03/01/2001 | WO2001014536A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 03/01/2001 | WO2001014535A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 03/01/2001 | WO2001014533A2 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans |
| 03/01/2001 | WO2001014532A2 Alkaline bacillus amylase |
| 03/01/2001 | WO2001014531A1 Cell-free assay for plant gene targeting and conversion |
| 03/01/2001 | WO2001014530A2 Method for growing stem cells |
| 03/01/2001 | WO2001014529A1 Compositions and methods for improved cell culture |
| 03/01/2001 | WO2001014523A1 TktA |
| 03/01/2001 | WO2001014521A1 A method for decreasing the foam formation during cultivation of a microorganism |
| 03/01/2001 | WO2001014519A2 Methods and compositions for regulating developmental identity |
| 03/01/2001 | WO2001014424A2 Human ctla-4 antibodies and their uses |
| 03/01/2001 | WO2001014422A1 Sequence derived from a human mammary gland cdna library |
| 03/01/2001 | WO2001014421A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 03/01/2001 | WO2001014420A2 Novel members of the plexin family and uses thereof |
| 03/01/2001 | WO2001014418A2 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF |
| 03/01/2001 | WO2001014417A2 Pesticidal proteins |
| 03/01/2001 | WO2001014416A2 Synthetic papillomavirus genes optimized for expression in human cells |
| 03/01/2001 | WO2001014415A2 Egfh2 genes and gene products |
| 03/01/2001 | WO2001014414A2 Human abc2 transporter and uses thereof |
| 03/01/2001 | WO2001014411A1 Recombinant subunit vaccine |
| 03/01/2001 | WO2001014404A1 A polynucleotide encoding a human junctional adhesion protein (jam-2) |
| 03/01/2001 | WO2001014402A1 Antisense modulation of focal adhesion kinase expression |
| 03/01/2001 | WO2001014400A1 2'-o-acetamido modified monomers and oligomers |
| 03/01/2001 | WO2001014387A1 28-epirapalogs |
| 03/01/2001 | WO2001013959A1 Method for knocking out gene expression by covalently binding antisense probes |
| 03/01/2001 | WO2001013958A2 Drug conjugates and methods of designing the same |
| 03/01/2001 | WO2001013944A2 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 03/01/2001 | WO2001013934A1 Peptide and peptide analogues for the treatment and prevention of diabetes |
| 03/01/2001 | WO2001013914A1 High affinity dna binding compounds as adjuvants in antisense technology |
| 03/01/2001 | WO2001013723A1 Charge reversal of polyion complexes |
| 03/01/2001 | WO2001013716A1 α-TOCOPHEROL TRANSPORT PROTEIN KNOCKOUT ANIMAL |
| 03/01/2001 | WO2001013715A2 Animal model and uses thereof |
| 03/01/2001 | WO2001013707A1 Improved method for the transformation and regeneration of plants |
| 03/01/2001 | WO2000078948A3 Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor |
| 03/01/2001 | WO2000077208A3 Gustatory receptors in drosophila |
| 03/01/2001 | WO2000075365A3 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 03/01/2001 | WO2000073449B1 Dna encoding snorf33 receptor |
| 03/01/2001 | WO2000073445A3 Interleukin-1-receptor associated kinase-3 (irak3) |
| 03/01/2001 | WO2000073415A3 A method for the transfer of antigens to dendritic cells |